TLR2 & NOD2-Based Adjuvant (VAdv-Ly0016)
| CAT | Size | Price | Quantity | |
|---|---|---|---|---|
| VAdv-Ly0016 |
|
A TLR2 & NOD2-based vaccine adjuvant.
Datasheet
Specifications
Type
PRRs Agonist
Formula
C74H128N6O17S
Molecular Weight
1405.90
Product Form
White powder
Endotoxin
Lower than 1 EU/mg.
Storage
Store at -20°C.
Shelf Life
1 year
Adjuvant Information
Introduction
The TLR2 and NOD2-based adjuvant compound consists of murabutide, a ligand for NOD2, covalently attached to Pam2C, a ligand for TLR2, through a spacer molecule. This compound has been demonstrated to induce synergistic maturation of human dendritic cells in vitro and significantly augment both systemic and mucosal immune responses to a vaccine antigen.
Related Product
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
